BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36555343)

  • 1. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
    Tai J; Park J; Han M; Kim TH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
    Zhang JZ; Wu ZH; Cheng Q
    Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Song Y; Feng T; Cao W; Yu H; Zhang Z
    Comput Intell Neurosci; 2022; 2022():9022700. PubMed ID: 35712071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
    Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
    Yu-Jing T; Wen-Jing T; Biao T
    Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
    Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis.
    Zou Z; Gan S; Liu S; Li R; Huang J
    Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
    Wang B; Wang W; Wang H; Liu W
    Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Highly Expressed IFIT1 in Nasopharyngeal Carcinoma Enhances Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
    Wu X; Lin L; Zhou F; Yu S; Chen M; Wang S
    Mol Biotechnol; 2022 Jun; 64(6):621-636. PubMed ID: 35038119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
    Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
    Gao P; Lu W; Hu S; Zhao K
    Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of key genes and pathways in pelvic organ prolapse based on gene expression profiling by bioinformatics analysis.
    Zhou Q; Hong L; Wang J
    Arch Gynecol Obstet; 2018 May; 297(5):1323-1332. PubMed ID: 29546564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.